SOM INNOVATION BIOTECH SA
🇪🇸Spain
Clinical Trials
5
Active:3
Completed:2
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)Efficacy and Safety on SOM3355 in Huntington's Disease Chorea
Phase 2
Active, not recruiting
- Conditions
- Huntington Chorea
- Interventions
- Drug: SOM3355 capsulesDrug: Placebo capsules
- First Posted Date
- 2022-07-27
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- SOM Innovation Biotech SA
- Target Recruit Count
- 129
- Registration Number
- NCT05475483
- Locations
- 🇫🇷
Centre Hospitalier Universitaire Angers, Angers, France
🇫🇷CHU Hôpital Henri Mondor (APHP), Créteil, France
🇫🇷Hôpital Roger Salengro - CHU Lille, Lille, France
Efficacy and Safety of SOM3355 in Huntington's Disease Chorea
Phase 2
Completed
- Conditions
- Huntington's Chorea
- Interventions
- Drug: SOM3355 100mg BIDDrug: SOM3355 200mg BIDDrug: Placebo BID
- First Posted Date
- 2018-07-02
- Last Posted Date
- 2019-09-16
- Lead Sponsor
- SOM Innovation Biotech SA
- Target Recruit Count
- 32
- Registration Number
- NCT03575676
- Locations
- 🇪🇸
Hospital Clínic de Barcelona, Barcelona, Spain
🇪🇸Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
🇪🇸Hospital Universitari Vall d'Hebron, Barcelona, Spain
Study of SOM0226 in Familial Amyloid Polyneuropathy
- First Posted Date
- 2014-07-16
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- SOM Innovation Biotech SA
- Target Recruit Count
- 17
- Registration Number
- NCT02191826
- Locations
- 🇪🇸
Hospital Vall d'Hebron, Barcelona, Catalonia, Spain
News
No news found